Study to Assess Efficacy of Risedronate in Preventing Bone Loss in Postmenopausal Women Treated for Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Menopause|Osteopenia
Interventions: DRUG: Risedronate|DRUG: Placebo
Sponsor: Hospices Civils de Lyon